The advice to detect and treat cancers at the first opportunity may not apply to older men with prostate tumors, according to …
Analyzing a tumor’s genes can predict which prostate cancers won’t need additional treatment and which cases require more intensive therapies.
Amid questions about how effective blood-based tests for prostate cancer might be, a new study suggests early screening with the test could identify about half of future deaths from the disease.
An aging population coupled with improved treatment methods mean more people will survive cancer. But at what cost?
Men who lose their hair may have more to worry about than just vanity, especially if their balding starts early.
Latest study adds to growing understanding of potential link between World Trade Center debris and cancer
Getting yearly physicals makes intuitive sense—routine checkups can pick up early signs of disease and get you on treatment that could save your life. Or can they?
Some 90% of cancer patients with metastatic breast, prostate, lung or colon cancers develop resistance to chemotherapy, and now scientists may have a clue as to why
According to a U.S. government advisory panel, almost no one should get screened for prostate cancer. But a new study this week reflects the continued view of many physicians — that screening does help to catch tumors earlier. …
Men who have early-stage prostate cancer will live just as long if they forgo surgery, which carries risks of impotence and incontinence, and simply do nothing but watch their cancer, according to the results of the largest …
A new study suggests that we can scale up production of poppy plants that produce a potent anti-cancer agent.
When it comes to complex medical decisions, cold hard statistics may hold little sway over patients in the face of a single, compelling anecdote.
A government panel finds there is little evidence that a common prostate-cancer screening saves men’s lives and instead raises the risk of unnecessary harm